Cite
HARVARD Citation
Moss, D. et al. (2021). Do non-dihydropyridine calcium channel blockers decrease progression of chronic kidney disease?. Evidence-based practice. 24 (6), pp. 36-38. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moss, D. et al. (2021). Do non-dihydropyridine calcium channel blockers decrease progression of chronic kidney disease?. Evidence-based practice. 24 (6), pp. 36-38. [Online].